Loading...
Docoh

National Instruments (NATI)

Cover Page

Cover Page - shares3 Months Ended
Mar. 31, 2022Apr. 25, 2022
Cover [Abstract]
Document Type10-Q
Document Quarterly Reporttrue
Document Period End DateMar. 31,
2022
Document Transition Reportfalse
Entity File Number000-25426
Entity Registrant NameNATIONAL INSTRUMENTS CORPORATION
Entity Incorporation, State or Country CodeDE
Entity Tax Identification Number74-1871327
Entity Address, Address Line One11500 North MoPac Expressway
Entity Address, City or TownAustin,
Entity Address, State or ProvinceTX
Entity Address, Postal Zip Code78759
City Area Code512
Local Phone Number683-0100
Title of 12(b) SecurityCommon Stock, $0.01 par value
Trading SymbolNATI
Security Exchange NameNASDAQ
Entity Current Reporting StatusYes
Entity Interactive Data CurrentYes
Entity Filer CategoryLarge Accelerated Filer
Entity Small Businessfalse
Entity Emerging Growth Companyfalse
Entity Shell Companyfalse
Entity Common Stock, Shares Outstanding131,173,958
Entity Central Index Key0000935494
Current Fiscal Year End Date--12-31
Document Fiscal Year Focus2022
Document Fiscal Period FocusQ1
Amendment Flagfalse

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Assets
Cash and cash equivalents $ 142,883 $ 211,106
Accounts receivable, net312,939 341,275
Inventories, net307,892 289,243
Prepaid expenses and other current assets109,764 89,925
Total current assets873,478 931,549
Property and equipment, net253,976 253,668
Goodwill592,074 575,992
Intangible assets, net216,292 220,418
Operating lease right-of-use assets60,931 58,641
Other long-term assets74,717 74,717
Total assets2,071,468 2,114,985
Liabilities and stockholders' equity
Accounts payable and accrued expenses81,824 83,218
Accrued compensation51,461 111,261
Deferred revenue - current134,640 137,818
Operating lease liabilities - current13,265 13,137
Other taxes payable57,600 59,109
Other current liabilities51,154 40,671
Total current liabilities389,944 445,214
Deferred income taxes11,583 14,249
Income taxes payable - non-current54,195 54,195
Deferred revenue - non-current35,766 32,822
Operating lease liabilities - non-current32,584 30,468
Debt, non-current325,000 300,000
Other long-term liabilities14,958 14,340
Total liabilities864,030 891,288
Commitments and contingencies
Stockholders' equity:
Preferred stock:  par value $0.01;  5,000,000 shares authorized; none issued and outstanding 0 0
Common stock:  par value $0.01;  360,000,000 shares authorized; 131,876,464 shares and 132,293,898 shares issued and outstanding, respectively 1,319 1,323
Additional paid-in capital1,152,349 1,129,647
Retained earnings76,264 112,858
Accumulated other comprehensive loss(22,494)(20,131)
Total stockholders’ equity1,207,438 1,223,697
Total liabilities and stockholders' equity $ 2,071,468 $ 2,114,985

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / sharesMar. 31, 2022Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value per share (in usd per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares)5,000,000 5,000,000
Preferred stock, issued (in shares)0 0
Preferred stock, outstanding (in shares)0 0
Common stock, par value per share (in usd per share) $ 0.01 $ 0.01
Common stock, authorized (in shares)360,000,000 360,000,000
Common stock, issued (in shares)131,876,464 132,293,898
Common stock, outstanding (in shares)131,876,464 132,293,898

Consolidated Statements Of Inco

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Net sales:
Total net sales $ 385,256 $ 335,182
Cost of sales:
Total cost of sales119,227 95,414
Gross profit266,029 239,768
Operating expenses:
Sales and marketing120,157 116,783
Research and development82,161 80,086
General and administrative33,179 33,358
Total operating expenses235,497 230,227
Operating income30,532 9,541
Other income (expense)33 (5,070)
Income before income taxes30,565 4,471
Provision (benefit) for income taxes5,329 (24)
Net income $ 25,236 $ 4,495
Basic earnings per share (in usd per share) $ 0.19 $ 0.03
Weighted average shares outstanding - basic (in shares)132,105 131,483
Diluted earnings per share (in usd per share) $ 0.19 $ 0.03
Weighted average shares outstanding - diluted (in shares)133,175 132,717
Dividends declared per share (in usd per share) $ 0.28 $ 0.27
Product
Net sales:
Total net sales $ 343,685 $ 295,092
Cost of sales:
Total cost of sales115,024 91,657
Software maintenance
Net sales:
Total net sales41,571 40,090
Cost of sales:
Total cost of sales $ 4,203 $ 3,757

Consolidated Statements Of Comp

Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income $ 25,236 $ 4,495
Other comprehensive income, before tax and net of reclassification adjustments:
Foreign currency translation adjustment(3,805)(7,195)
Unrealized loss on securities available-for-sale0 (88)
Unrealized gain on derivative instruments1,867 11,981
Other comprehensive (loss) income, before tax(1,938)4,698
Tax expense related to items of other comprehensive income425 2,760
Other comprehensive (loss) income, net of tax(2,363)1,938
Comprehensive income $ 22,873 $ 6,433

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Cash flow from operating activities:
Net income $ 25,236 $ 4,495
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization21,566 23,872
Stock-based compensation20,128 17,189
(Gain) loss from equity-method investees(602)4,173
Deferred income taxes(3,615)(3,746)
Changes in operating assets and liabilities, net of acquisitions(66,561)(16,142)
Net cash (used in) provided by operating activities(3,848)29,841
Cash flow from investing activities:
Acquisitions, net of cash received(17,510)0
Capital expenditures(10,182)(8,488)
Capitalization of internally developed software(187)(226)
Additions to other intangibles(1,274)(1,018)
Payments to acquire equity-method investments0 (11,539)
Sales and maturities of short-term investments0 27,664
Net cash (used in) provided by investing activities(29,153)6,393
Cash flow from financing activities:
Proceeds from revolving line of credit25,000 0
Payments on term loan0 (1,250)
Proceeds from issuance of common stock9,244 8,565
Repurchase of common stock(31,455)0
Dividends paid(36,976)(35,533)
Net cash used in financing activities(34,187)(28,218)
Effect of exchange rate changes on cash(1,035)(1,536)
Net change in cash and cash equivalents(68,223)6,480
Cash and cash equivalents at beginning of period211,106 260,232
Cash and cash equivalents at end of period $ 142,883 $ 266,712

Consolidated Statements Of Stoc

Consolidated Statements Of Stockholders' Equity - USD ($) $ in ThousandsTotalCommon StockAdditional-Paid in CapitalRetained EarningsAccumulated Other Comprehensive Income/(Loss)
Beginning balance (in shares) at Dec. 31, 2020131,246,615
Beginning balance at Dec. 31, 2020 $ 1,224,871 $ 1,312 $ 1,033,284 $ 211,101 $ (20,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income4,495 4,495
Other comprehensive (loss) income, net of tax1,938 1,938
Issuance of common stock under employee plans (in shares)360,421
Issuance of common stock under employee plans8,565 $ 4 8,561
Stock-based compensation17,173 17,173
Dividends paid[1](35,533)(35,533)
Ending balance (in shares) at Mar. 31, 2021131,607,036
Ending Balance at Mar. 31, 2021 $ 1,221,509 $ 1,316 1,059,018 180,063 (18,888)
Beginning balance (in shares) at Dec. 31, 2021132,293,898 132,293,898
Beginning balance at Dec. 31, 2021 $ 1,223,697 $ 1,323 1,129,647 112,858 (20,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income25,236 25,236
Other comprehensive (loss) income, net of tax(2,363)(2,363)
Issuance of common stock under employee plans (in shares)354,618
Issuance of common stock under employee plans9,244 $ 4 9,240
Stock-based compensation20,055 20,055
Repurchase of common stock (in shares)(772,052)
Repurchase of common stock(31,455) $ (8)(6,593)(24,854)
Dividends paid[1] $ (36,976)(36,976)
Ending balance (in shares) at Mar. 31, 2022131,876,464 131,876,464
Ending Balance at Mar. 31, 2022 $ 1,207,438 $ 1,319 $ 1,152,349 $ 76,264 $ (22,494)
[1]Cash dividends declared per share of common stock were $0.28 and $0.27 for the three months ended March 31, 2022 and 2021, respectively.

Consolidated Statements Of St_2

Consolidated Statements Of Stockholders' Equity (Parenthetical) - $ / shares3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (in usd per share) $ 0.28 $ 0.27

Basis of presentation

Basis of presentation3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentationBasis of presentation The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 22, 2022 (the "2021 Form 10-K"). In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to present fairly our financial position at March 31, 2022 and December 31, 2021, the results of our operations and comprehensive income for the three months ended March 31, 2022 and 2021, the cash flows for the three months ended March 31, 2022 and 2021, and the statement of stockholders' equity for the three months ended March 31, 2022 and 2021. Our operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). Recently Adopted Accounting Pronouncements In November 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-10 (“ASU 2021-10”), Government Assistance , to increase transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. ASU 2021-10 is effective for annual periods beginning after December 15, 2021. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our consolidated financial statements and related disclosures. In November 2021, the FASB issued ASU No. 2021-08—Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with ASC Topic 606 as if the acquirer had originated the contracts. We early adopted the standard on January 1, 2022. The adoption of this accounting standard update did not have a material effect on our consolidated financial statements and related disclosures. Summary of Significant Accounting Policies There were no material changes to our significant accounting policies during the three months ended March 31, 2022 compared to the significant accounting policies described in our 2021 Form 10-K. Other (Expense) Income Other (expense) income, net consisted of the following amounts (in thousands): Three Months Ended March 31, (Unaudited) 2022 2021 Interest income $ 46 $ 161 Interest expense (1,292) (704) Gain (loss) from equity-method investments 602 (4,173) Net foreign exchange loss (1,166) (559) Other 1,843 205 Other (expense) income, net $ 33 $ (5,070) Other Current Liabilities Other current liabilities on our consolidated balance sheet includes the following amounts (in thousands): As of March 31, 2022 As of December 31, (unaudited) 2021 Income taxes payable - current $ 19,925 $ 14,457 Hedge payable - current 7,759 7,091 Other 23,470 19,123 Total $ 51,154 $ 40,671 Earnings Per Share Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes restricted stock units ("RSUs"), is computed using the treasury stock method. The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three months ended March 31, 2022 and 2021 are as follows (in thousands): Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Weighted average shares outstanding-basic 132,105 131,483 Plus: Common share equivalents RSUs 1,070 1,234 Weighted average shares outstanding-diluted 133,175 132,717 Shares issuable upon vesting of RSU awards for the three months ended March 31, 2022 and 2021 of 442,000 shares and 567,000 shares, respectively, were excluded in the computations of diluted EPS because the effect of including the RSU awards would have been anti-dilutive.

Revenue

Revenue3 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
RevenueRevenue Revenue Recognition Revenue is recognized upon transfer of control of the promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. We enter into contracts that can include various combinations of our products or services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities. Disaggregation of Revenues We disaggregate revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time), geographic region based on the billing location of the customer, and customer industry grouping. Total net sales based on the timing of transfer of goods or services to customers and geographic region are as follows: Three Months Ended March 31, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 132,988 $ 26,222 $ 159,210 $ 104,586 $ 22,147 $ 126,733 EMEA 79,241 21,129 100,370 64,237 21,285 85,522 APAC 114,995 10,681 125,676 112,630 10,297 122,927 Total net sales (1) $ 327,224 $ 58,032 $ 385,256 $ 281,453 $ 53,729 $ 335,182 (1): Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. The industry grouping used to disaggregate net sales is determined at the customer account level. Accounts assigned to one of our three industry-specific groupings are either designated as Semiconductor and Electronics, Transportation, or Aerospace, Defense, and Government ("ADG"). We are able to leverage the investments in these areas to also serve a broad base of diverse customers in the other industries we serve, which are included in our Portfolio grouping. Three Months Ended March 31, (In thousands) (Unaudited) Industry Grouping 2022 2021 Portfolio $ 126,582 $ 112,352 Semiconductor & Electronics 103,012 98,930 Aerospace, Defense & Government 92,672 76,269 Transportation 62,990 47,631 Total net sales $ 385,256 $ 335,182 Information about Contract Balances Amounts collected in advance of services being provided are accounted for as deferred revenue. Nearly all of our deferred revenue balance is related to extended hardware and software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers, such as invoicing at the beginning of a subscription term with a portion of the revenue recognized ratably over the contract period, or to provide customers with financing, such as multi-year on-premises licenses that are invoiced annually with revenue recognized upfront. Changes in deferred revenue, current and non-current, during the three months ended March 31, 2022 were as follows: Amount (In thousands) Deferred Revenue at December 31, 2021 $ 170,640 Deferral of revenue billed in current period, net of recognition 52,457 Recognition of revenue deferred in prior periods (50,515) Foreign currency translation impact (2,175) Balance as of March 31, 2022 (unaudited) $ 170,407 For the three months ended March 31, 2022, revenue recognized from performance obligations satisfied in prior periods (for example, due to changes in transaction price) was not material. Amounts recognized as revenue in excess of amounts billed are recorded as unbilled receivables. Unbilled receivables which are anticipated to be invoiced in the next twelve months are included in "other current assets" on the consolidated balance sheet. Based on the nature of our contracts with customers, we do not typically recognize unbilled receivables related to revenues recognized in excess of amounts billed. For the three months ended March 31, 2022 and December 31, 2021, amounts recognized related to unbilled receivables were not material. Unsatisfied Performance Obligations Revenue expected to be recognized in any future period related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less, and contracts where revenue is recognized as invoiced, was approximately $66.4 million as of March 31, 2022. Because we typically invoice customers at contract inception, this amount is included in our current and non-current deferred revenue balances and primarily relates to multi-year payments for hardware service and software service offerings. As of March 31, 2022, we expect to recognize approximately 38% of the revenue related to these unsatisfied performance obligations during the remainder of 2022, 36% during 2023, and 26% thereafter. Assets Recognized from the Costs to Obtain a Contract with a Customer

Investments

Investments3 Months Ended
Mar. 31, 2022
Cash, Cash Equivalents, and Short-term Investments [Abstract]
InvestmentsInvestments Equity-Method Investments The carrying value of our equity method investments was $32 million and $32 million as of March 31, 2022 and December 31, 2021, respectively. During the three months ended March 31, 2022 and 2021, net sales to our equity-method investees were approximately $1.5 million and $0.3 million, respectively and purchases from our equity-method investees were not material. We recorded a $3.5 million impairment loss related to an equity-method investment during the three months ended March 31, 2021. Our proportionate share of the income/(loss) from equity-method investments and related impairment charges are included within "Other (expense) income". Refer to Note 1 - Basis of Presentation of Notes to Consolidated Financial Statements for additional information on these amounts for the three months ended March 31, 2022 and 2021.

Fair value measurements

Fair value measurements3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair value measurementsFair value measurements We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability. We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following: Level 1 – Quoted prices in active markets for identical assets or liabilities Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly Level 3 – Inputs that are not based on observable market data Assets and liabilities measured at fair value on a recurring basis are summarized below: Fair Value Measurements at Reporting Date Using (In thousands) (Unaudited) Description March 31, 2022 Level 1 Level 2 Level 3 Assets Cash and cash equivalents available for sale: Money Market Funds $ 2,042 $ 2,042 $ — $ — Other assets: Derivatives 14,852 — 14,852 Total Assets $ 16,894 $ 2,042 $ 14,852 $ — Liabilities Derivatives $ (10,118) $ — $ (10,118) $ — Total Liabilities $ (10,118) $ — $ (10,118) $ — (In thousands) Fair Value Measurements at Reporting Date Using Description December 31, 2021 Level 1 Level 2 Level 3 Assets Cash and cash equivalents available for sale: Money Market Funds $ 101,290 $ 101,290 $ — $ — Other assets: Derivatives 12,407 — 12,407 — Total Assets $ 113,697 $ 101,290 $ 12,407 $ — Liabilities Derivatives $ (9,468) $ — $ (9,468) $ — Total Liabilities $ (9,468) $ — $ (9,468) $ — We value our available-for-sale short-term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government organizations and agencies. Derivatives include foreign currency forward contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the three months ended March 31, 2022. There were no transfers in or out of Level 1 or Level 2 during the three months ended March 31, 2022. We did not have any items that were measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021. The carrying value of net accounts receivable, accounts payable, and long-term debt contained in the consolidated balance sheets approximates fair value.

Derivative instruments and hedg

Derivative instruments and hedging activities3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative instruments and hedging activitiesDerivative instruments and hedging activities We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. We have direct operations in approximately 40 countries. Sales outside of the Americas accounted for approximately 59% and 62% of our net sales during the three months ended March 31, 2022 and 2021, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program. We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, in that exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors. The vast majority of our foreign sales are denominated in the customers’ local currency. We use foreign currency forward contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated financial assets or liabilities. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also use foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of sales expenses will be adversely affected by changes in exchange rates. We designate foreign currency forward contracts as cash flow hedges of forecasted net sales or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature. Cash flow hedges To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative is reported as a component of accumulated other comprehensive income ("OCI") and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Hedge effectiveness of foreign currency forwards designated as cash flow hedges is measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value. We held forward contracts designated as cash flow hedges with the following notional amounts: (In thousands) US Dollar Equivalent As of March 31, 2022 As of December 31, (Unaudited) 2021 Chinese yuan $ 87,871 $ 99,066 Euro 121,396 145,351 Japanese yen 33,460 43,128 Hungarian forint 46,749 54,939 British pound 23,981 25,947 Malaysian ringgit 24,161 29,624 Korean won 10,923 21,180 Total forward contracts notional amount $ 348,541 $ 419,235 The contracts in the foregoing table had contractual maturities of 21 months or less and 24 months or less at March 31, 2022 and December 31, 2021, respectively. At March 31, 2022, we expect to reclassify $8.1 million of gains on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, $1.9 million of losses on derivative instruments from accumulated OCI to cost of sales during the next twelve months when the cost of sales are incurred and $1.4 million of losses on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at March 31, 2022. Actual results may vary materially as a result of changes in the corresponding exchange rates subsequent to this date. Other Derivatives Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated monetary assets and liabilities to help protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 90 days or less. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “Other (expense) income.” As of March 31, 2022 and December 31, 2021, we held foreign currency forward contracts that were not designated as hedging instruments with a notional amount of $102 million and $94 million, respectively. The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at March 31, 2022 and December 31, 2021, respectively. Asset Derivatives March 31, 2022 December 31, 2021 (Unaudited) (In thousands) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 11,386 $ 8,993 Foreign exchange contracts - LT forwards Other long-term assets 2,449 2,908 Total derivatives designated as hedging instruments $ 13,835 $ 11,901 Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 1,017 $ 506 Total derivatives not designated as hedging instruments $ 1,017 $ 506 Total derivatives $ 14,852 $ 12,407 Liability Derivatives March 31, 2022 December 31, 2021 (Unaudited) (In thousands) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (6,514) $ (6,425) Foreign exchange contracts - LT forwards Other long-term liabilities (2,354) (2,377) Total derivatives designated as hedging instruments $ (8,868) $ (8,802) Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (1,250) $ (666) Total derivatives not designated as hedging instruments $ (1,250) $ (666) Total derivatives $ (10,118) $ (9,468) The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the three-months ended March 31, 2022 and 2021, respectively: March 31, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 1,884 Net sales $ 1,739 Foreign exchange contracts - forwards (21) Cost of sales (327) Foreign exchange contracts - forwards 4 Operating expenses (239) Total $ 1,867 $ 1,173 March 31, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 16,286 Net sales $ (2,026) Foreign exchange contracts - forwards (2,529) Cost of sales (21) Foreign exchange contracts - forwards (1,776) Operating expenses (9) Total $ 11,981 $ (2,056) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income March 31, 2022 March 31, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other (expense) income $ (803) (1,601) Total $ (803) $ (1,601)

Inventories, net

Inventories, net3 Months Ended
Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories, netInventories, net Inventories, net consist of the following: March 31, 2022 December 31, (In thousands) (Unaudited) 2021 Raw materials $ 196,514 $ 181,676 Work-in-process 16,247 14,573 Finished goods 95,131 92,994 Total $ 307,892 $ 289,243

Intangible assets and goodwill,

Intangible assets and goodwill, net3 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets and goodwill, netIntangible assets and goodwill, net Intangible assets at March 31, 2022 and December 31, 2021 are as follows: March 31, 2022 (In thousands) (Unaudited) December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Capitalized software development costs $ 44,554 $ (37,262) $ 7,292 $ 45,671 $ (36,457) $ 9,214 Acquired technology 151,531 (39,788) 111,743 148,155 (34,264) 113,891 Customer relationships 96,966 (21,606) 75,360 93,931 (19,717) 74,214 Patents 36,498 (29,879) 6,619 36,217 (29,316) 6,901 Other 33,986 (18,708) 15,278 32,962 (16,764) 16,198 Total $ 363,535 $ (147,243) $ 216,292 $ 356,936 $ (136,518) $ 220,418 Software development costs capitalized for the three months ended March 31, 2022 and 2021 were $0.2 million and $0.3 million, respectively, and related amortization expenses for the three months ended March 31, 2022 and 2021 were $2.0 million and $7 million, respectively. Amortization of capitalized software development costs is computed on an individual product basis for those products available for market and is recognized based on the product’s estimated economic life, which generally range from three five ten Goodwill The carrying amount of goodwill as of March 31, 2022 was as follows: Amount (In thousands) Balance as of December 31, 2021 $ 575,992 Acquisitions 13,516 Measurement period adjustment 5,085 Foreign currency translation impact (2,519) Balance as of March 31, 2022 (unaudited) $ 592,074 The excess purchase price over the fair value of assets acquired is recorded as goodwill. As businesses are acquired, we assign assets acquired (including goodwill) and liabilities assumed to either our existing reporting unit or a newly identified reporting unit as of the date of the acquisition. In the event a disposal group meets the definition of a business, goodwill is allocated to the disposal group based on the relative fair value of the disposal group to the related reporting unit. As we have one operating segment comprised of components with similar economic characteristics, we allocate goodwill to one reporting unit for goodwill impairment testing. Goodwill is tested for impairment on an annual basis, and between annual tests if indicators of potential impairment exist, using a fair-value-based approach based on the market capitalization of the reporting unit. Our annual impairment test is performed in the fourth quarter of each year.

Leases

Leases3 Months Ended
Mar. 31, 2022
Leases [Abstract]
LeasesLeases We have operating leases for corporate offices, automobiles, and certain equipment. Our leases have remaining terms of 1 year to 92 years, some of which may include options to extend the leases for up to 9 years, and some of which may include options to terminate the leases within 1 year. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for these leases on a straight-line basis over the lease term. Amounts related to finance lease activities and income from leasing activities were not material for the periods presented. The components of operating lease expense were as follows (unaudited): (In thousands) March 31, 2022 March 31, 2021 Operating Lease Cost (1) $ 5,417 $ 5,330 (1) includes variable and short-term lease costs Maturities of lease liabilities as of March 31, 2022 were as follows (unaudited): (In thousands) Years ending December 31, Operating Leases 2022 (Excluding the three months ended March 31, 2022) $ 11,496 2023 11,776 2024 9,973 2025 7,069 2026 6,193 Thereafter 2,921 Total future minimum lease payments 49,428 Less imputed interest (3,579) Total lease liabilities $ 45,849 As of March 31, 2022, we have additional operating leases that have not commenced during the period, which were not material.

Income taxes

Income taxes3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income taxesIncome taxes We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established when necessary to reduce deferred tax assets to amounts which are more likely than not to be realized. We had a valuation allowance of $84 million at March 31, 2022 and December 31, 2021. A majority of the valuation allowance is related to the deferred tax assets of National Instruments Hungary Kft. (“NI Hungary”). We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. We had $10.1 million and $9.4 million of gross unrecognized tax benefits at March 31, 2022 and December 31, 2021, respectively, all of which would affect our effective income tax rate if recognized. We recorded a gross increase in unrecognized tax benefits of $779,000 for the three months ended March 31, 2022, as a result of the tax positions taken during this period. As of March 31, 2022, it is reasonably possible that we will recognize gross tax benefits in the amount of $1.5 million in the next twelve months due to the closing of open tax years. The nature of the uncertainty is related to positions taken on returns that have not been examined by the applicable tax authority. Our continuing policy is to recognize interest and penalties related to income tax matters in income tax expense. During the three months ended March 31, 2022, we recognized interest expense related to uncertain tax positions of approximately $26,000. As of March 31, 2022, we had approximately $0.3 million accrued for interest related to uncertain tax positions. The tax years 2015 through 2022 remain open to examination by the major taxing jurisdictions to which we are subject. Our provision for income taxes reflected an effective tax rate of 17% and (1)% for the three months ended March 31, 2022 and 2021, respectively. For the three months ended March 31, 2022, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of deduction for foreign-derived intangible income, an enhanced deduction for certain research and development expenses and the research and development tax credit, offset by the change in unrecognized tax benefits, nondeductible officer compensation, state income taxes net of federal benefit and U.S. tax on global intangible low-taxed income. For the three months ended March 31, 2021, our effective tax rate was lower than the U.S. federal statutory rate of 21% primarily as a result of excess tax benefits from share-based compensation and other discrete items, an enhanced deduction for certain research and development expenses, the research and development tax credit, and the deduction for foreign-derived intangible income, offset by the U.S. tax on global intangible low-taxed income, state income taxes net of federal benefit and nondeductible officer compensation. Our earnings in Hungary are subject to a statutory tax rate of 9%. In addition, our research and development activities in Hungary benefit from a tax law in Hungary that provides for an enhanced deduction for qualified research and development expenses. The tax position of our Hungarian operations resulted in income tax benefits of $2.0 million and $0.2 million for the three months ended March 31, 2022, and March 31, 2021, respectively. Earnings from our operations in Malaysia are free of tax under a tax holiday effective January 1, 2013. This tax holiday expires in 2037. If we fail to satisfy the conditions of the tax holiday, this tax benefit may be terminated early. The income tax benefits of the tax holiday for the three months ended March 31, 2022, and March 31, 2021 were approximately $0.6 million and $0.1 million, respectively. The impact of the tax holiday on a per share basis for each of the three months ended March 31, 2022 and March 31, 2021 was a benefit of $0.01 per share. No other taxing jurisdictions had a significant impact on our effective tax rate. We have not entered into any advanced pricing or other agreements with the Internal Revenue Service ("IRS") with regard to any foreign jurisdictions.

Comprehensive Income

Comprehensive Income3 Months Ended
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Comprehensive incomeComprehensive income Our OCI is comprised of net income, foreign currency translation adjustments, and unrealized gains and losses on forward contracts and securities classified as available-for-sale. The accumulated OCI, net of tax, for the three months ended March 31, 2022 and 2021, consisted of the following: March 31, 2022 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2021 $ (23,179) $ — 3,048 $ (20,131) Current-period other comprehensive (loss) income (3,805) — 3,040 (765) Reclassified from accumulated OCI into income — — (1,173) (1,173) Income tax (benefit) expense — — 425 425 Balance as of March 31, 2022 $ (26,984) $ — $ 4,490 $ (22,494) March 31, 2021 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2020 $ (10,066) $ (426) (10,334) $ (20,826) Current-period other comprehensive (loss) income (7,195) (88) 9,925 2,642 Reclassified from accumulated OCI into income — — 2,056 2,056 Income tax (benefit) expense — (2) 2,762 2,760 Balance as of March 31, 2021 $ (17,261) $ (512) $ (1,115) $ (18,888)

Authorized shares of common and

Authorized shares of common and preferred stock and stock-based compensation plans3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Authorized shares of common and preferred stock and stock-based compensation plansAuthorized shares of common and preferred stock and stock-based compensation plans Authorized shares of common and preferred stock The total number of shares which we are authorized to issue is 365,000,000 shares, consisting of (i) 5,000,000 shares of preferred stock, par value $0.01 per share, and (ii) 360,000,000 shares of common stock, par value $0.01 per share. Stock-Based Compensation Plan Our stockholders approved our 2005 Incentive Plan (the “2005 Plan”) on May 10, 2005. At the time of approval, 4,050,000 shares of our common stock were reserved for issuance under the 2005 Plan, as well as the number of shares which had been reserved but not issued under our 1994 Incentive Stock Options Plan (the “1994 Plan”), which terminated in May 2005, and any shares that returned to the 1994 Plan as a result of termination of options or repurchase of shares issued under such plan. The 2005 Plan provided for the granting of incentive awards in the form of restricted stock and RSUs to directors, executive officers and employees of the Company and its subsidiaries. Awards vest over a three five Our stockholders approved our 2010 Incentive Plan (the “2010 Plan”) on May 11, 2010. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under the 2010 Plan, as well as the 3,362,304 shares of common stock that were reserved but not issued under the 1994 Plan and the 2005 Plan as of May 11, 2010, and any shares that are returned to the 1994 Plan and the 2005 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2010 Plan provided for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards vest over a three five Our stockholders approved our 2015 Equity Incentive Plan (the “2015 Plan”) on May 12, 2015. At the time of approval, 3,000,000 shares of our common stock were reserved for issuance under the 2015 Plan, as well as the 2,518,416 shares of common stock that were reserved but not issued under the 2010 Plan as of May 12, 2015, and any shares that were returned to the 1994 Plan, 2005 Plan, and the 2010 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2015 Plan provides for the granting of incentive awards in the form of restricted stock and RSUs, to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company and such awards may be subject to performance-based vesting conditions. Awards generally vest over a three four five Our stockholders approved our 2020 Equity Incentive Plan (the “2020 Plan”) on May 5, 2020. At the time of approval, 4,500,000 shares of our common stock were reserved for issuance under the 2020 Plan, as well as the 567,142 shares of common stock that were reserved but not issued under the 2015 Plan as of May 5, 2020, and any shares that were returned to the 1994 Plan, 2005 Plan, 2010 Plan, and 2015 Plan as a result of the forfeiture or termination of options or RSUs or repurchase of shares issued under those plans. The 2020 Plan provides for the granting of incentive awards in the form of restricted stock and RSUs to employees, directors and consultants of the Company and employees and consultants of any parent or subsidiary of the Company. Awards generally vest over a one two three Performance-based stock units During the three months ended March 31, 2022 and 2021, we granted 164,843 and 130,006 performance-based restricted stock units ("PRSUs"), respectively, to executive officers pursuant to the 2020 Plan and 2015 Plan. The PRSUs may be earned based on our total shareholder return ("TSR") compared to the TSR of the Russell 2000 Index (the “Index”) over a three-year performance period. For the PRSUs granted during the three months ended March 31, 2022, the three-year performance period commenced on January 1, 2022, and will end on December 31, 2024, and for the PRSUs granted during the three months ended March 31, 2021, the three-year performance commenced on January 1, 2021 and will end on December 31, 2023, using the average daily closing price over a 30-day lookback in each case. The number of awards earned could range from zero to two times the target number of shares granted. The fair values of PRSUs are estimated using a Monte Carlo simulation. The determination of fair value of the PRSUs is based on our stock price and a number of assumptions including the expected volatility, expected dividend yield and the risk-free interest rate. The expected volatility at the date of grant was based on the historical volatilities of our stock and the companies included in the Index over the performance period. The Monte Carlo model is based on random projections of stock-price paths and must be repeated numerous times to achieve a probabilistic assessment. The key assumptions used in valuing these market-based awards are as follows: Three Months Ended (unaudited) March 31, 2022 March 31, 2021 Number of simulations 100,000 100,000 Expected volatility 37.81% 40.60% Expected life in years 2.95 years 2.95 years Risk-free interest rate 1.33% 0.21% Dividend yield 2.52% 2.66% The weighted average grant date fair value of the market-based awards, as determined by the Monte Carlo valuation model, was $59.65 per share and $66.97 per share in 2022 and 2021, respectively. Employee stock purchase plan Our employee stock purchase plan ("ESPP") permits substantially all domestic employees and employees of designated subsidiaries to acquire our common stock at a purchase price of 85% of the lower of the market price at the beginning or the end of the purchase period. The plan has quarterly purchase periods generally beginning on February 1, May 1, August 1 and November 1 of each year. Employees may designate up to 15% of their compensation for the purchase of common stock under the ESPP. On May 14, 2019, our stockholders approved an additional 3,000,000 shares for issuance under our ESPP. At March 31, 2022, we had 1,797,679 shares of common stock reserved for future issuance under the ESPP. We issued 263,842 shares under this plan in the three months ended March 31, 2022 and the weighted average purchase price of the shares issued was $35.04 per share. During the three months ended March 31, 2022, we did not make any changes in accounting principles or methods of estimates with respect to our ESPP. Authorized Preferred Stock and Preferred Stock Purchase Rights Plan We have 5,000,000 authorized shares of preferred stock. On January 21, 2004, our Board of Directors designated 750,000 of these shares as Series A Participating Preferred Stock in conjunction with the adoption of a Preferred Stock Rights Agreement which expired on May 10, 2014. There were no shares of preferred stock issued and outstanding at March 31, 2022. Stock repurchases and retirements On April 21, 2010, our Board of Directors authorized a program to repurchase of shares of our common stock from time to time, depending on market conditions and other factors (the “2019 Program”). The Board has amended the 2019 Program several times over the years to increase the number of shares that may be purchased under the program. On October 23, 2019, our Board amended the 2019 Program to increase the number of shares that may be repurchased by 3,000,000 shares. At March 31, 2022, there were 0 shares remaining available for repurchase under the 2019 Program and there was $230 million available for repurchase under the 2022 Program. We repurchased 772,052 shares of our common stock at a weighted average price per share of $40.74 during the three-months ended March 31, 2022 under the 2019 Program and 2022 Program. We did not repurchase any shares

Segment and geographic informat

Segment and geographic information3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]
Segment and geographic informationSegment and geographic information We operate as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is our chief executive officer, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker evaluates our financial information and resources and assesses the performance of these resources on a consolidated basis. Since we operate as one operating segment, all required financial segment information can be found in the condensed consolidated financial statements and the notes thereto. We sell our products in three geographic regions which consist of: the Americas; Europe, Middle East and Africa region ("EMEA"); and Asia-Pacific region ("APAC"). Our sales to these regions share similar economic characteristics including the nature of products and services we sell, the type and class of customers, and the methods used to distribute our products and services. Revenue from the sale of our products, which are similar in nature, and software maintenance is reflected as total net sales in our Consolidated Statements of Income. (See Note 2 –Revenue of Notes to Consolidated Financial Statements for total net sales by the major geographic areas in which we operate). The following table present summarized information for net sales by country. Revenues from external customers are generally attributed to countries based upon the customer's location. Net sales attributable to each individual foreign country outside the U.S. and China were not material. (in millions) United States China (1) Rest of the World Total Net sales: Three months ended March 31, 2022 $ 152 55 178 $ 385 Three months ended March 31, 2021 $ 120 54 161 $ 335 (1): Includes Mainland China and the Hong Kong Special Administrative Region The following table presents summarized information for long-lived assets by country. Long-lived assets attributable to each individual country outside the U.S., Hungary and Malaysia were not material. Long-lived assets consist of property, plant, and equipment and operating lease right-of-use assets and excludes intangible assets. (in millions) United States Hungary Malaysia Rest of the World Total Long-lived Assets: March 31, 2022 $ 126 52 77 60 $ 315 December 31, 2021 $ 125 51 76 60 $ 312

Debt

Debt3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]
DebtDebt On June 18, 2021, we entered into the Second Amended and Restated Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, as the administrative agent, swingline lender and issuing lender (the “Administrative Agent”), Wells Fargo Securities, LLC, as sole lead arranger and bookrunner, and the lenders party thereto. The Credit Agreement amended and restated and refinanced our prior Amended and Restated Credit Agreement, dated as of June 12, 2020 (as further amended on October 30, 2020, the "Prior Credit Agreement"), by and among us, the lenders from time-to-time party thereto and Administrative Agent. All outstanding loans under the Prior Credit Agreement were repaid in full in connection with the entry into the Credit Agreement. The Credit Agreement provides for a secured revolving loan facility in an aggregate principal amount of up to $500 million at any time outstanding with sublimit of $25 million for the issuance of letters of credit. Subject to the terms of the Credit Agreement, including obtaining commitments from existing lenders or new lenders, we may request term loans or additional revolving commitments. Pursuant the Credit Agreement, the revolving line of credit terminates, and all revolving loans under the Credit Agreement will be due and payable, on June 18, 2026. The revolving loans and term loans accrue interest, at our option, at: (i) a base rate equal to the highest of (a) the prime rate (b) the federal funds rate plus 0.50%, and (c) LIBOR for an interest period of one month plus 1.00%, in each case, plus a margin of 0.25% to 0.75%; or (ii) LIBOR plus a margin of 1.25% to 1.75%, with the margin being determined based upon our consolidated total net leverage ratio. The Credit Agreement contains financial covenants requiring us to maintain a maximum total leverage ratio of less than or equal to 3.50 to 1.00 which increases to 4.00 to 1.00 for a specified period following material acquisitions, and a minimum interest coverage ratio of greater than or equal to 3.00 to 1.00, in each case determined in accordance with the Credit Agreement. The Credit Agreement provides for a commitment fee of 0.150% to 0.250% per annum, determined based upon our consolidated total net leverage ratio, on the average daily unused amount of the revolving committed amount, payable quarterly in arrears. Under the circumstances described in the Credit Agreement, certain of our wholly owned domestic subsidiaries (the "Subsidiary Guarantors") are required to enter into a guaranty agreement ("Guaranty") in favor of the Administrative Agent guarantying the obligations of the Company under the Credit Agreement, among other things. As of December 31, 2021, there were no Subsidiary Guarantors, and no Guaranty had been executed in connection with the Credit Agreement. In connection with the Credit Agreement, we have entered (and our future Subsidiary Guarantors will enter into an Amended and Restated Collateral Agreement pursuant to which we and our Subsidiary Guarantors from time-to-time have granted (or will grant) a lien on substantially all of our and their assets to secure our and their obligations under the Credit Agreement and the Guaranty. The Credit Agreement contains customary affirmative and negative covenants. The affirmative covenants include, among other things, delivery of financial statements, compliance certificates and notices, payment of taxes and other obligations, maintenance of existence, maintenance of properties and insurance, maintenance of books and records, and compliance with applicable laws and regulations. The negative covenants include, among other things, limitations on indebtedness, liens, mergers, consolidations, acquisitions and sales of assets, investments, changes in the nature of the business, affiliate transactions and certain restricted payments. The Credit Agreement contains customary events of default including, among other things, payment defaults, breaches of covenants or representations and warranties, cross-defaults with certain other indebtedness, bankruptcy and insolvency events, judgment defaults and change in control events, subject to grace periods in certain instances. Upon an event of default, the Administrative Agent and the Lenders may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Credit Agreement. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Credit Agreement at a per annum rate of interest equal to 2.00% above the otherwise applicable interest rate. Proceeds of revolving loans of the Credit Agreement may be used for working capital and other general corporate purposes. We may prepay the loans under the Credit Agreement in whole or in part at any time without premium or penalty. The following table presents the amounts outstanding related to our borrowing arrangements discussed above as of March 31, 2022, and December 31, 2021, respectively (in thousands): March 31, December 31, 2022 2021 Secured 2021 revolving loan facility (effective interest rate of 1.4%) 325,000 300,000 Total Debt, non-current $ 325,000 $ 300,000 As of March 31, 2022, debt issuance costs of approximately $2.4 million attributable to our revolving credit facility are presented within "Other long-term assets" in our Consolidated Balance Sheet. These amounts are amortized to interest expense ratably over the life of the revolving line of credit.

Commitments and contingencies

Commitments and contingencies3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingenciesCommitments and contingencies We offer a one-year limited warranty on most hardware products which is included in the terms of sale of such products. We also offer optional extended warranties on our hardware products for which the related revenue is recognized ratably over the warranty period. Provision is made for estimated future warranty costs at the time of the sale for the estimated costs that may be incurred under the standard warranty. Our estimate is based on historical experience and product sales during the period. The warranty reserve for the three months ended March 31, 2022 and 2021 was as follows: Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Balance at the beginning of the period $ 3,210 $ 2,872 Accruals for warranties issued during the period 641 681 Accruals related to pre-existing warranties 83 130 Settlements made (in cash or in kind) during the period (584) (803) Balance at the end of the period $ 3,350 $ 2,880

Restructuring

Restructuring3 Months Ended
Mar. 31, 2022
Restructuring and Related Activities [Abstract]
RestructuringRestructuringOn October 26, 2021, we initiated a restructuring plan (the “2021 Plan”) that will result in the site closure of our facilities in Aachen, Germany. This targeted restructuring effort is intended to further optimize our research and development operations and accelerate investment in strategic growth opportunities. In connection with the 2021 Plan, the majority of these charges were recognized during the fourth quarter of 2021. A summary of the charges in our consolidated statement of operations resulting from our restructuring activities is shown below: Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Cost of sales $ — $ 75 Research and development 400 155 Sales and marketing — 4,086 General and administrative — 1,959 Total restructuring and other related costs $ 400 $ 6,275 Total restructuring and other charges incurred during the three months ended March 31, 2022 related to the 2021 Plan were $0.4 million primarily related to employee severance costs. A summary of balance sheet activity during 2022 related to the restructuring activity is shown below: Restructuring Liability (in thousands) Balance as of December 31, 2021 $ 11,520 Income statement expense 400 Cash payments (2,107) Balance as of March 31, 2022 $ 9,813 The restructuring liability of $9.8 million at March 31, 2022 relating primarily to severance payments associated with the restructuring activity, is recorded in the “accrued compensation” line item of our consolidated balance sheet.

Litigation

Litigation3 Months Ended
Mar. 31, 2022
Litigation Settlement [Abstract]
LitigationLitigation    We are not currently a party to any material litigation. However, in the ordinary course of our business, we have in the past, are currently and may likely become involved in various legal proceedings, claims, and regulatory, tax or government inquiries and investigations, and could incur uninsured liability in any one or more of them. We also periodically receive notifications from various third parties related to alleged infringement of patents or intellectual property rights, commercial disputes or other matters. No assurances can be given with respect to the extent or outcome of any investigation, litigation or dispute.

Acquisitions

Acquisitions3 Months Ended
Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
AcquisitionsAcquisitions Acquisition of Electronic Vehicle (“EV”) Business From Heinzinger Electronic GmbH ("Heinzinger") On February 28, 2022, we completed the acquisition of the systems business of Heinzinger for $22.5 million in total cash consideration, subject to certain post-closing adjustments. This transaction was accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of Heinzinger have been recorded at their respective fair values as of the acquisition date. We recognized approximately $14 million of goodwill and $7 million of other intangible assets as part of our preliminary purchase price allocation. Transaction costs have been expensed as incurred and were not material to the periods presented. The acquisition was funded by cash on hand. The preliminary purchase price allocation related to the acquisition was not finalized as of March 31, 2022, and is based upon a preliminary valuation which is subject to change as we obtain additional information with respect to certain intangible assets and income taxes. Pro-forma results of operations have not been presented as the impact of the acquired operations was not material. The excess of the purchase price over the net assets acquired was recorded as goodwill. Goodwill generated from the acquisition is primarily attributable to expected growth in the scope of and market opportunities for our existing offerings related to vehicle electrification and other related applications. Goodwill is not deductible for tax purposes. Acquisition of N H Research, LLC ("NHR") On October 19, 2021, we completed the acquisition of NHR, a manufacturer of test and measurement solutions for high power applications including EV and batteries. As a result of acquiring 100% of the outstanding share capital of NHR, NHR became our wholly owned subsidiary. This transaction is being accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of NHR have been recorded at their respective fair values as of the acquisition date. Transaction costs have been expensed as incurred. The acquisition was funded primarily by cash on hand in addition to $200 million drawn under our existing credit facility in October 2021. See Note 13 – Debt of Notes to Consolidated Financial Statements for further information on our outstanding borrowings. During the year ended December 31, 2021, we expensed $6 million of transaction costs in connection with the acquisition of NHR, which are included in selling, general and administrative expenses. At the acquisition date, total consideration transferred was approximately $206 million, inclusive of $3 million in cash acquired. The excess of the purchase price over the net assets acquired was recorded as goodwill. Goodwill generated from the acquisition is primarily attributable to expected growth in the scope of and market opportunities for our existing offerings related to vehicle electrification and other related applications. As a result of the structure of the transaction, the balance of goodwill is deductible in the U.S. over 15 years for income tax purposes. During the first quarter of 2022, we recorded a measurement period adjustment to our preliminary estimate of the fair value of liabilities assumed related to amounts owed for certain pre-acquisition activities. The increase to the fair value of acquired liabilities was $5.1 million, with a corresponding increase to goodwill. The change to this provisional amount had no impact to the current period income statement. Fair value of net assets acquired and liabilities assumed The information below represents the preliminary purchase price allocation of NHR (in thousands): October 19, 2021 Consideration Transferred $ 206,238 Cash 2,935 Accounts receivable, net 3,902 Inventories, net 4,764 Property and equipment, net 287 Other assets and liabilities (4,621) Intangible assets 98,510 Goodwill 102,932 Accounts payable and accrued expenses (2,186) Deferred revenue (285) Net assets acquired $ 206,238 Our preliminary estimates of the fair value of the assets acquired and the liabilities assumed are based on the information currently available, and we are continuing to evaluate the underlying inputs and assumptions used in our valuations. Accordingly, these preliminary estimates are subject to change during the measurement period, which is up to one year from the date of acquisition. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the acquisition would result in a corresponding increase in the amount of goodwill acquired. The primary areas of the purchase price that are not yet finalized relate to income taxes, certain liabilities related to preacquisition activities, and residual goodwill. Acquired intangible assets will be amortized over their estimated useful lives on a straight-line basis. The following table summarizes the preliminary purchase price allocation, and the preliminary average remaining useful lives, for identifiable intangible assets acquired (dollars in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships $ 54,350 7 Developed software 6,010 2-7 Existing product configurations 28,300 9 In-process research and development (IPR&D) 4,030 Indefinite Trade name 5,820 6 Total $ 98,510 Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers. Customer relationships were valued using the multi-period excess earnings method of the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by customer relationships less charges representing the contribution of other assets to those cash flows. The economic useful life was determined by examining the period of time over which a target cumulative present value of discounted cash flows could be achieved. Existing product configurations represent the existing hardware configurations of products sold by NHR. These products are created from component parts and assembled based on their intended purpose and application. Existing product configurations were valued using the avoided costs / lost profits method. The fair value represents the total costs that would be avoided by having this asset in place. The economic useful life was determined based on the number of years since launch for each product compared to the expected total life of each product. Unaudited Pro Forma Information The following unaudited pro forma financial information presents combined results of operations for the periods presented, as if the NHR acquisition had occurred on January 1, 2020, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. These pro forma adjustments include additional amortization expense for the identifiable intangible assets and an increase in interest expense related to the additional borrowings entered into in connection with the acquisition, net of tax effects. For the pro forma presentation, given the assumed acquisition date of January 1, 2020, transaction and integration costs that were incurred at or subsequent to the actual acquisition date have been included in the calculation of pro forma net income for the three months ended March 31, 2021, whereas transaction and integration costs that were incurred prior to the acquisition date have been excluded from the calculation of pro forma net income. The unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what actual results of operations would have been if the acquisition had occurred as the beginning of the period presented, nor are they indicative of future results of operations. The unaudited pro forma results do not include the impact of synergies, nor any potential impacts on current or future market conditions which could alter the unaudited pro forma results. Three Months Ended March 31, (in thousands) 2021 Net sales $ 342,935 Net income $ 3,884 Other Acquisitions During the second quarter of 2021, we also completed the acquisition of MonoDrive, a software company that specializes in signal processing and hi-fi simulation software for validation of autonomous vehicles and advanced driver assistance systems (ADAS), for approximately $20 million in total cash consideration, subject to certain post-closing adjustments. This transaction was accounted for as a business combination using the acquisition method of accounting. All of the acquired assets and liabilities of the software company have been recorded at their respective fair values as of the acquisition date. We recognized approximately $17 million of goodwill and $4 million of other intangible assets as part of our purchase price allocation. Transaction costs have been expensed as incurred and were not material to the periods presented. Pro-forma results of operations have not been presented because the effects of the acquired operations were not material. The excess of the purchase price over the net assets acquired was recorded as goodwill. Goodwill generated from the acquisition is primarily attributable to expected growth in the scope of and market opportunities for our software-defined automated test and measurement platform. Goodwill is not deductible for tax purposes.

Subsequent events

Subsequent events3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent eventsSubsequent events  On April 20, 2022, our Board of Directors declared a quarterly cash dividend of $0.28 per common share, payable on May 31, 2022, to stockholders of record on May 9, 2022.

Basis of presentation (Policies

Basis of presentation (Policies)3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentationBasis of presentation   The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 22, 2022 (the "2021 Form 10-K"). In our opinion, the accompanying consolidated financial statements reflect all adjustments (consisting only of normal recurring items) considered necessary to present fairly our financial position at March 31, 2022 and December 31, 2021, the results of our operations and comprehensive income for the three months ended March 31, 2022 and 2021, the cash flows for the three months ended March 31, 2022 and 2021, and the statement of stockholders' equity for the three months ended March 31, 2022 and 2021. Our operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP").
Recently Adopted Accounting Pronouncements and Summary of Significant Accounting PoliciesRecently Adopted Accounting Pronouncements In November 2021, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2021-10 (“ASU 2021-10”), Government Assistance , to increase transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. ASU 2021-10 is effective for annual periods beginning after December 15, 2021. Early adoption is permitted. We are currently evaluating the impact of this accounting standard update on our consolidated financial statements and related disclosures. In November 2021, the FASB issued ASU No. 2021-08—Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with ASC Topic 606 as if the acquirer had originated the contracts. We early adopted the standard on January 1, 2022. The adoption of this accounting standard update did not have a material effect on our consolidated financial statements and related disclosures. Summary of Significant Accounting Policies There were no material changes to our significant accounting policies during the three months ended March 31, 2022 compared to the significant accounting policies described in our 2021 Form 10-K.
Earnings Per ShareEarnings Per Share Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which includes restricted stock units ("RSUs"), is computed using the treasury stock method.

Basis of presentation (Tables)

Basis of presentation (Tables)3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other (Expense) Income, netOther (expense) income, net consisted of the following amounts (in thousands): Three Months Ended March 31, (Unaudited) 2022 2021 Interest income $ 46 $ 161 Interest expense (1,292) (704) Gain (loss) from equity-method investments 602 (4,173) Net foreign exchange loss (1,166) (559) Other 1,843 205 Other (expense) income, net $ 33 $ (5,070)
Schedule of Other Current LiabilitiesOther current liabilities on our consolidated balance sheet includes the following amounts (in thousands): As of March 31, 2022 As of December 31, (unaudited) 2021 Income taxes payable - current $ 19,925 $ 14,457 Hedge payable - current 7,759 7,091 Other 23,470 19,123 Total $ 51,154 $ 40,671
Schedule of Reconciliation of the Denominators used to Calculate Basic and Diluted EPSThe reconciliation of the denominators used to calculate basic EPS and diluted EPS for the three months ended March 31, 2022 and 2021 are as follows (in thousands): Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Weighted average shares outstanding-basic 132,105 131,483 Plus: Common share equivalents RSUs 1,070 1,234 Weighted average shares outstanding-diluted 133,175 132,717

Revenue (Tables)

Revenue (Tables)3 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of RevenueTotal net sales based on the timing of transfer of goods or services to customers and geographic region are as follows: Three Months Ended March 31, (Unaudited) 2022 2021 (In thousands) Net sales: Point-in-Time (1) Over Time Total Point-in-Time (1) Over Time Total Americas $ 132,988 $ 26,222 $ 159,210 $ 104,586 $ 22,147 $ 126,733 EMEA 79,241 21,129 100,370 64,237 21,285 85,522 APAC 114,995 10,681 125,676 112,630 10,297 122,927 Total net sales (1) $ 327,224 $ 58,032 $ 385,256 $ 281,453 $ 53,729 $ 335,182 (1): Net sales contains hedging gains and losses, which do not represent revenues recognized from customers. The industry grouping used to disaggregate net sales is determined at the customer account level. Accounts assigned to one of our three industry-specific groupings are either designated as Semiconductor and Electronics, Transportation, or Aerospace, Defense, and Government ("ADG"). We are able to leverage the investments in these areas to also serve a broad base of diverse customers in the other industries we serve, which are included in our Portfolio grouping. Three Months Ended March 31, (In thousands) (Unaudited) Industry Grouping 2022 2021 Portfolio $ 126,582 $ 112,352 Semiconductor & Electronics 103,012 98,930 Aerospace, Defense & Government 92,672 76,269 Transportation 62,990 47,631 Total net sales $ 385,256 $ 335,182
Schedule of Changes in Unearned RevenueChanges in deferred revenue, current and non-current, during the three months ended March 31, 2022 were as follows: Amount (In thousands) Deferred Revenue at December 31, 2021 $ 170,640 Deferral of revenue billed in current period, net of recognition 52,457 Recognition of revenue deferred in prior periods (50,515) Foreign currency translation impact (2,175) Balance as of March 31, 2022 (unaudited) $ 170,407

Fair value measurements (Tables

Fair value measurements (Tables)3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring BasisAssets and liabilities measured at fair value on a recurring basis are summarized below: Fair Value Measurements at Reporting Date Using (In thousands) (Unaudited) Description March 31, 2022 Level 1 Level 2 Level 3 Assets Cash and cash equivalents available for sale: Money Market Funds $ 2,042 $ 2,042 $ — $ — Other assets: Derivatives 14,852 — 14,852 Total Assets $ 16,894 $ 2,042 $ 14,852 $ — Liabilities Derivatives $ (10,118) $ — $ (10,118) $ — Total Liabilities $ (10,118) $ — $ (10,118) $ — (In thousands) Fair Value Measurements at Reporting Date Using Description December 31, 2021 Level 1 Level 2 Level 3 Assets Cash and cash equivalents available for sale: Money Market Funds $ 101,290 $ 101,290 $ — $ — Other assets: Derivatives 12,407 — 12,407 — Total Assets $ 113,697 $ 101,290 $ 12,407 $ — Liabilities Derivatives $ (9,468) $ — $ (9,468) $ — Total Liabilities $ (9,468) $ — $ (9,468) $ —

Derivative instruments and he_2

Derivative instruments and hedging activities (Tables)3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Forward Contracts Notional AmountWe held forward contracts designated as cash flow hedges with the following notional amounts: (In thousands) US Dollar Equivalent As of March 31, 2022 As of December 31, (Unaudited) 2021 Chinese yuan $ 87,871 $ 99,066 Euro 121,396 145,351 Japanese yen 33,460 43,128 Hungarian forint 46,749 54,939 British pound 23,981 25,947 Malaysian ringgit 24,161 29,624 Korean won 10,923 21,180 Total forward contracts notional amount $ 348,541 $ 419,235
Schedule of Fair Value of Derivative InstrumentsThe following tables present the fair value of derivative instruments on our Consolidated Balance Sheets at March 31, 2022 and December 31, 2021, respectively. Asset Derivatives March 31, 2022 December 31, 2021 (Unaudited) (In thousands) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 11,386 $ 8,993 Foreign exchange contracts - LT forwards Other long-term assets 2,449 2,908 Total derivatives designated as hedging instruments $ 13,835 $ 11,901 Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Prepaid expenses and other current assets $ 1,017 $ 506 Total derivatives not designated as hedging instruments $ 1,017 $ 506 Total derivatives $ 14,852 $ 12,407 Liability Derivatives March 31, 2022 December 31, 2021 (Unaudited) (In thousands) Balance Sheet Location Fair Value Fair Value Derivatives designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (6,514) $ (6,425) Foreign exchange contracts - LT forwards Other long-term liabilities (2,354) (2,377) Total derivatives designated as hedging instruments $ (8,868) $ (8,802) Derivatives not designated as hedging instruments Foreign exchange contracts - ST forwards Other current liabilities $ (1,250) $ (666) Total derivatives not designated as hedging instruments $ (1,250) $ (666) Total derivatives $ (10,118) $ (9,468)
Schedule of Effect of Derivative InstrumentsThe following tables present the effect of derivative instruments on our Consolidated Statements of Income for the three-months ended March 31, 2022 and 2021, respectively: March 31, 2022 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 1,884 Net sales $ 1,739 Foreign exchange contracts - forwards (21) Cost of sales (327) Foreign exchange contracts - forwards 4 Operating expenses (239) Total $ 1,867 $ 1,173 March 31, 2021 (In thousands) (Unaudited) Derivatives in Cash Flow Hedging Relationship Gain or (Loss) Recognized in OCI on Derivative Location of Gain or (Loss) Reclassified from Accumulated OCI into Income Gain or (Loss) Reclassified from Accumulated OCI into Income Foreign exchange contracts - forwards $ 16,286 Net sales $ (2,026) Foreign exchange contracts - forwards (2,529) Cost of sales (21) Foreign exchange contracts - forwards (1,776) Operating expenses (9) Total $ 11,981 $ (2,056) (In thousands) Derivatives not Designated as Hedging Instruments Location of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income Amount of Gain (Loss) Recognized in Income March 31, 2022 March 31, 2021 (Unaudited) (Unaudited) Foreign exchange contracts - forwards Other (expense) income $ (803) (1,601) Total $ (803) $ (1,601)

Inventories, net (Tables)

Inventories, net (Tables)3 Months Ended
Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory, NetInventories, net consist of the following: March 31, 2022 December 31, (In thousands) (Unaudited) 2021 Raw materials $ 196,514 $ 181,676 Work-in-process 16,247 14,573 Finished goods 95,131 92,994 Total $ 307,892 $ 289,243

Intangible assets and goodwil_2

Intangible assets and goodwill, net (Tables)3 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible AssetsIntangible assets at March 31, 2022 and December 31, 2021 are as follows: March 31, 2022 (In thousands) (Unaudited) December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Capitalized software development costs $ 44,554 $ (37,262) $ 7,292 $ 45,671 $ (36,457) $ 9,214 Acquired technology 151,531 (39,788) 111,743 148,155 (34,264) 113,891 Customer relationships 96,966 (21,606) 75,360 93,931 (19,717) 74,214 Patents 36,498 (29,879) 6,619 36,217 (29,316) 6,901 Other 33,986 (18,708) 15,278 32,962 (16,764) 16,198 Total $ 363,535 $ (147,243) $ 216,292 $ 356,936 $ (136,518) $ 220,418
Schedule of GoodwillThe carrying amount of goodwill as of March 31, 2022 was as follows: Amount (In thousands) Balance as of December 31, 2021 $ 575,992 Acquisitions 13,516 Measurement period adjustment 5,085 Foreign currency translation impact (2,519) Balance as of March 31, 2022 (unaudited) $ 592,074

Leases (Tables)

Leases (Tables)3 Months Ended
Mar. 31, 2022
Leases [Abstract]
Components of Lease ExpenseThe components of operating lease expense were as follows (unaudited): (In thousands) March 31, 2022 March 31, 2021 Operating Lease Cost (1) $ 5,417 $ 5,330 (1) includes variable and short-term lease costs
Schedule of Future Minimum Lease PaymentsMaturities of lease liabilities as of March 31, 2022 were as follows (unaudited): (In thousands) Years ending December 31, Operating Leases 2022 (Excluding the three months ended March 31, 2022) $ 11,496 2023 11,776 2024 9,973 2025 7,069 2026 6,193 Thereafter 2,921 Total future minimum lease payments 49,428 Less imputed interest (3,579) Total lease liabilities $ 45,849

Comprehensive income (Tables)

Comprehensive income (Tables)3 Months Ended
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Comprehensive Income (Loss)The accumulated OCI, net of tax, for the three months ended March 31, 2022 and 2021, consisted of the following: March 31, 2022 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2021 $ (23,179) $ — 3,048 $ (20,131) Current-period other comprehensive (loss) income (3,805) — 3,040 (765) Reclassified from accumulated OCI into income — — (1,173) (1,173) Income tax (benefit) expense — — 425 425 Balance as of March 31, 2022 $ (26,984) $ — $ 4,490 $ (22,494) March 31, 2021 (Unaudited) (In thousands) Currency translation adjustment Investments Derivative instruments Accumulated other comprehensive income/(loss) Balance as of December 31, 2020 $ (10,066) $ (426) (10,334) $ (20,826) Current-period other comprehensive (loss) income (7,195) (88) 9,925 2,642 Reclassified from accumulated OCI into income — — 2,056 2,056 Income tax (benefit) expense — (2) 2,762 2,760 Balance as of March 31, 2021 $ (17,261) $ (512) $ (1,115) $ (18,888)

Authorized shares of common a_2

Authorized shares of common and preferred stock and stock-based compensation plans (Tables)3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Key Assumptions to Value Market-based AwardsThe key assumptions used in valuing these market-based awards are as follows: Three Months Ended (unaudited) March 31, 2022 March 31, 2021 Number of simulations 100,000 100,000 Expected volatility 37.81% 40.60% Expected life in years 2.95 years 2.95 years Risk-free interest rate 1.33% 0.21% Dividend yield 2.52% 2.66%

Segment and geographic inform_2

Segment and geographic information (Tables)3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Net Sales by CountryThe following table present summarized information for net sales by country. Revenues from external customers are generally attributed to countries based upon the customer's location. Net sales attributable to each individual foreign country outside the U.S. and China were not material. (in millions) United States China (1) Rest of the World Total Net sales: Three months ended March 31, 2022 $ 152 55 178 $ 385 Three months ended March 31, 2021 $ 120 54 161 $ 335 (1): Includes Mainland China and the Hong Kong Special Administrative Region The following table presents summarized information for long-lived assets by country. Long-lived assets attributable to each individual country outside the U.S., Hungary and Malaysia were not material. Long-lived assets consist of property, plant, and equipment and operating lease right-of-use assets and excludes intangible assets. (in millions) United States Hungary Malaysia Rest of the World Total Long-lived Assets: March 31, 2022 $ 126 52 77 60 $ 315 December 31, 2021 $ 125 51 76 60 $ 312

Debt (Tables)

Debt (Tables)3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Amounts Outstanding Related to Borrowing ArrangementsThe following table presents the amounts outstanding related to our borrowing arrangements discussed above as of March 31, 2022, and December 31, 2021, respectively (in thousands): March 31, December 31, 2022 2021 Secured 2021 revolving loan facility (effective interest rate of 1.4%) 325,000 300,000 Total Debt, non-current $ 325,000 $ 300,000

Commitments and contingencies (

Commitments and contingencies (Tables)3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty LiabilityThe warranty reserve for the three months ended March 31, 2022 and 2021 was as follows: Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Balance at the beginning of the period $ 3,210 $ 2,872 Accruals for warranties issued during the period 641 681 Accruals related to pre-existing warranties 83 130 Settlements made (in cash or in kind) during the period (584) (803) Balance at the end of the period $ 3,350 $ 2,880

Restructuring (Tables)

Restructuring (Tables)3 Months Ended
Mar. 31, 2022
Restructuring and Related Activities [Abstract]
Summary of Charges Resulting From Restructuring ActivitiesA summary of the charges in our consolidated statement of operations resulting from our restructuring activities is shown below: Three Months Ended March 31, (In thousands) (Unaudited) 2022 2021 Cost of sales $ — $ 75 Research and development 400 155 Sales and marketing — 4,086 General and administrative — 1,959 Total restructuring and other related costs $ 400 $ 6,275
Schedule of Restructuring Reserve by Type of CostA summary of balance sheet activity during 2022 related to the restructuring activity is shown below: Restructuring Liability (in thousands) Balance as of December 31, 2021 $ 11,520 Income statement expense 400 Cash payments (2,107) Balance as of March 31, 2022 $ 9,813

Acquisitions (Tables)

Acquisitions (Tables)3 Months Ended
Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Preliminary Purchase Price AllocationThe information below represents the preliminary purchase price allocation of NHR (in thousands): October 19, 2021 Consideration Transferred $ 206,238 Cash 2,935 Accounts receivable, net 3,902 Inventories, net 4,764 Property and equipment, net 287 Other assets and liabilities (4,621) Intangible assets 98,510 Goodwill 102,932 Accounts payable and accrued expenses (2,186) Deferred revenue (285) Net assets acquired $ 206,238
Summary of Preliminary Purchase Price Allocation and Useful LivesThe following table summarizes the preliminary purchase price allocation, and the preliminary average remaining useful lives, for identifiable intangible assets acquired (dollars in thousands): Estimated Fair Value Estimated Useful Lives (in years) Customer relationships $ 54,350 7 Developed software 6,010 2-7 Existing product configurations 28,300 9 In-process research and development (IPR&D) 4,030 Indefinite Trade name 5,820 6 Total $ 98,510
Unaudited Pro Forma ResultsThree Months Ended March 31, (in thousands) 2021 Net sales $ 342,935 Net income $ 3,884

Basis of presentation - Schedul

Basis of presentation - Schedule of Other Income (Expense) (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest income $ 46 $ 161
Interest expense(1,292)(704)
Gain (loss) from equity-method investments602 (4,173)
Net foreign exchange loss(1,166)(559)
Other1,843 205
Other (expense) income, net $ 33 $ (5,070)

Basis of presentation - Sched_2

Basis of presentation - Schedule of Other Current Liabilities (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Income taxes payable - current $ 19,925 $ 14,457
Hedge payable - current7,759 7,091
Other23,470 19,123
Total $ 51,154 $ 40,671

Basis of presentation - Sched_3

Basis of presentation - Schedule of Earnings Per Share (Details) - shares shares in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Weighted average shares outstanding - basic (in shares)132,105 131,483
Plus: Common share equivalents
RSUs (in shares)1,070 1,234
Weighted average shares outstanding-diluted (in shares)133,175 132,717
RSU
Plus: Common share equivalents
Anti-dilutive securities excluded from the computation of diluted EPS (in shares)442 567

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenues (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Total net sales $ 385,256 $ 335,182
Portfolio
Disaggregation of Revenue [Line Items]
Total net sales126,582 112,352
Semiconductor & Electronics
Disaggregation of Revenue [Line Items]
Total net sales103,012 98,930
Aerospace, Defense & Government
Disaggregation of Revenue [Line Items]
Total net sales92,672 76,269
Transportation
Disaggregation of Revenue [Line Items]
Total net sales62,990 47,631
Americas
Disaggregation of Revenue [Line Items]
Total net sales159,210 126,733
EMEA
Disaggregation of Revenue [Line Items]
Total net sales100,370 85,522
APAC
Disaggregation of Revenue [Line Items]
Total net sales125,676 122,927
Point-in-Time
Disaggregation of Revenue [Line Items]
Total net sales327,224 281,453
Point-in-Time | Americas
Disaggregation of Revenue [Line Items]
Total net sales132,988 104,586
Point-in-Time | EMEA
Disaggregation of Revenue [Line Items]
Total net sales79,241 64,237
Point-in-Time | APAC
Disaggregation of Revenue [Line Items]
Total net sales114,995 112,630
Over Time
Disaggregation of Revenue [Line Items]
Total net sales58,032 53,729
Over Time | Americas
Disaggregation of Revenue [Line Items]
Total net sales26,222 22,147
Over Time | EMEA
Disaggregation of Revenue [Line Items]
Total net sales21,129 21,285
Over Time | APAC
Disaggregation of Revenue [Line Items]
Total net sales $ 10,681 $ 10,297

Revenue - Changes in Unearned R

Revenue - Changes in Unearned Revenue (Details) $ in Thousands3 Months Ended
Mar. 31, 2022USD ($)
Movement in Deferred Revenue [Roll Forward]
Deferred revenue, beginning balance $ 170,640
Deferral of revenue billed in current period, net of recognition52,457
Recognition of revenue deferred in prior periods50,515
Foreign currency translation impact(2,175)
Deferred revenue, ending balance $ 170,407

Revenue - Narrative (Details)

Revenue - Narrative (Details) $ in Millions3 Months Ended
Mar. 31, 2022USD ($)
Revenue from Contract with Customer [Abstract]
Payment termsAmounts collected in advance of services being provided are accounted for as deferred revenue. Nearly all of our deferred revenue balance is related to extended hardware and software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 90 days of contract inception.
Undelivered performance obligation $ 66.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent38.00%
Performance obligation, term9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent36.00%
Performance obligation, term1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent26.00%
Performance obligation, term

Investments (Details)

Investments (Details) - USD ($) $ in Millions3 Months Ended
Mar. 31, 2022Mar. 31, 2021Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Carrying value of equity method investments $ 32 $ 32
Impairment loss $ 3.5
Equity-Method Investment
Debt Securities, Available-for-sale [Line Items]
Net sales1.5 0.3
Purchase $ 0 $ 0

Fair value measurements (Detail

Fair value measurements (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Other assets:
Derivatives $ 14,852 $ 12,407
Total Assets 16,894 113,697
Derivatives(10,118)(9,468)
Total Liabilities (10,118)(9,468)
Level 1
Other assets:
Derivatives0 0
Total Assets 2,042 101,290
Derivatives0 0
Total Liabilities 0 0
Level 2
Other assets:
Derivatives14,852 12,407
Total Assets 14,852 12,407
Derivatives(10,118)(9,468)
Total Liabilities (10,118)(9,468)
Level 3
Other assets:
Derivatives 0
Total Assets 0 0
Derivatives0 0
Total Liabilities 0 0
Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents available for sale2,042 101,290
Money Market Funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents available for sale2,042 101,290
Money Market Funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents available for sale0 0
Money Market Funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents available for sale $ 0 $ 0

Derivative instruments and he_3

Derivative instruments and hedging activities - Narrative (Details) $ in Thousands3 Months Ended12 Months Ended
Mar. 31, 2022USD ($)countryMar. 31, 2021Dec. 31, 2021USD ($)
Derivative [Line Items]
Number of countries for which entity has direct operations | country40
Period of protection against the reduction in value caused by a fluctuation, minimum (in number of years)1 year
Period of protection against the reduction in value caused by a fluctuation, maximum (in number of years)3 years
Foreign currency forward contracts notional amount $ 348,541 $ 419,235
Forward Contracts
Derivative [Line Items]
Duration of time, foreign currency cash flow hedge40 months
Forward Contracts | Net sales
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings $ 8,100
Forward Contracts | Operating expenses
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings(1,900)
Forward Contracts | Cost of sales
Derivative [Line Items]
Gains (losses) expected to be reclassified from AOCI to earnings(1,400)
Other Derivatives
Derivative [Line Items]
Foreign currency forward contracts notional amount $ 102,000 $ 94,000
Maximum
Derivative [Line Items]
Duration of foreign currency forward contracts21 months24 months
Maximum | Forward Contracts
Derivative [Line Items]
Percentage of derivative risk hedged100.00%
Maximum | Other Derivatives
Derivative [Line Items]
Percentage of derivative risk hedged90.00%
Duration of foreign currency forward contracts90 days
Net sales | Geographic Concentration Risk | Non-Americas
Derivative [Line Items]
Concentration risk, percentage59.00%62.00%

Derivative instruments and he_4

Derivative instruments and hedging activities - Summary Of Notional Amounts Of Derivative Instruments (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Derivative [Line Items]
Total forward contracts notional amount $ 348,541 $ 419,235
Chinese yuan
Derivative [Line Items]
Total forward contracts notional amount87,871 99,066
Euro
Derivative [Line Items]
Total forward contracts notional amount121,396 145,351
Japanese yen
Derivative [Line Items]
Total forward contracts notional amount33,460 43,128
Hungarian forint
Derivative [Line Items]
Total forward contracts notional amount46,749 54,939
British pound
Derivative [Line Items]
Total forward contracts notional amount23,981 25,947
Malaysian ringgit
Derivative [Line Items]
Total forward contracts notional amount24,161 29,624
Korean won
Derivative [Line Items]
Total forward contracts notional amount $ 10,923 $ 21,180

Derivative instruments and he_5

Derivative instruments and hedging activities - Fair Values Of Derivative Instruments On Consolidated Balance Sheets (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative assets $ 14,852 $ 12,407
Derivative liability(10,118)(9,468)
Derivatives designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative assets13,835 11,901
Derivative liability(8,868)(8,802)
Derivatives designated as hedging instruments | Foreign exchange contracts - ST forwards | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets11,386 8,993
Derivatives designated as hedging instruments | Foreign exchange contracts - ST forwards | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability(6,514)(6,425)
Derivatives designated as hedging instruments | Foreign exchange contracts - LT forwards | Other long-term assets
Derivatives, Fair Value [Line Items]
Derivative assets2,449 2,908
Derivatives designated as hedging instruments | Foreign exchange contracts - LT forwards | Other long-term liabilities
Derivatives, Fair Value [Line Items]
Derivative liability(2,354)(2,377)
Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative assets1,017 506
Derivative liability(1,250)(666)
Derivatives not designated as hedging instruments | Foreign exchange contracts - ST forwards | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets1,017 506
Derivatives not designated as hedging instruments | Foreign exchange contracts - ST forwards | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability $ (1,250) $ (666)

Derivative instruments and he_6

Derivative instruments and hedging activities - Effect Of Derivative Instruments On Consolidated Statements Of Income (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Derivatives designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative $ 1,867 $ 11,981
Gain or (Loss) Reclassified from Accumulated OCI into Income1,173 (2,056)
Derivatives designated as hedging instruments | Foreign exchange contracts 1
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative1,884 16,286
Derivatives designated as hedging instruments | Foreign exchange contracts 1 | Net sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income1,739 (2,026)
Derivatives designated as hedging instruments | Foreign exchange contracts 2
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative(21)(2,529)
Derivatives designated as hedging instruments | Foreign exchange contracts 2 | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income(327)(21)
Derivatives designated as hedging instruments | Foreign exchange contracts 3
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Recognized in OCI on Derivative4 (1,776)
Derivatives designated as hedging instruments | Foreign exchange contracts 3 | Operating expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain or (Loss) Reclassified from Accumulated OCI into Income(239)(9)
Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income(803)(1,601)
Derivatives not designated as hedging instruments | Foreign exchange contracts - forwards
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income $ (803) $ (1,601)

Inventories, net (Details)

Inventories, net (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials   $ 196,514 $ 181,676
Work-in-process16,247 14,573
Finished goods95,131 92,994
Total $ 307,892 $ 289,243

Intangible assets and goodwil_3

Intangible assets and goodwill, net - Schedule Of Finite-Lived Intangible Assets (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount $ 363,535 $ 356,936
Accumulated Amortization(147,243)(136,518)
Net Carrying Amount216,292 220,418
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount44,554 45,671
Accumulated Amortization(37,262)(36,457)
Net Carrying Amount7,292 9,214
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount151,531 148,155
Accumulated Amortization(39,788)(34,264)
Net Carrying Amount111,743 113,891
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount96,966 93,931
Accumulated Amortization(21,606)(19,717)
Net Carrying Amount75,360 74,214
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount36,498 36,217
Accumulated Amortization(29,879)(29,316)
Net Carrying Amount6,619 6,901
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount33,986 32,962
Accumulated Amortization(18,708)(16,764)
Net Carrying Amount $ 15,278 $ 16,198

Intangible assets and goodwil_4

Intangible assets and goodwill, net - Narrative (Details)3 Months Ended12 Months Ended
Mar. 31, 2022USD ($)segmentMar. 31, 2021USD ($)Dec. 31, 2021USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets $ 12,400,000 $ 14,000,000
Number of operating segments | segment1
Goodwill impairment $ 0 $ 0
Capitalized software development costs
Finite-Lived Intangible Assets [Line Items]
Software development costs capitalized200,000 300,000
Amortization expense of capitalized software development costs $ 2,000,000 $ 7,000,000
Capitalized software development costs | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)3 years
Capitalized software development costs | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)6 years
Acquired technology | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)5 years
Acquired technology | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)10 years
Customer relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)5 years
Customer relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)10 years
Patents | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)10 years
Patents | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)17 years
Other | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)5 years
Other | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets amortization period (in years)10 years

Intangible assets and goodwil_5

Intangible assets and goodwill, net - Schedule of Goodwill (Details) $ in Thousands3 Months Ended
Mar. 31, 2022USD ($)
Goodwill [Roll Forward]
Balance at beginning of period $ 575,992
Acquisitions13,516
Measurement period adjustment5,085
Foreign currency translation impact(2,519)
Balance at end of period $ 592,074

Leases - Summary of Components

Leases - Summary of Components of Lease Expense and Other Information (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Lessee, Lease, Description [Line Items]
Operating lease, termination period1 year
Operating lease cost $ 5,417 $ 5,330
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term92 years
Operating lease, option to extend, term9 years

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) $ in ThousandsMar. 31, 2022USD ($)
Leases [Abstract]
2022 (Excluding the three months ended March 31, 2022) $ 11,496
202311,776
20249,973
20257,069
20266,193
Thereafter2,921
Total future minimum lease payments49,428
Less imputed interest(3,579)
Total lease liabilities $ 45,849

Income taxes (Details)

Income taxes (Details) - USD ($) $ / shares in Units, $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Valuation allowance $ 84,000 $ 84,000
Unrecognized tax benefits10,100 $ 9,400
Gross increase in unrecognized tax benefits, current period779
Reasonable possibility of future tax benefits1,500
Interest expense related to uncertain tax positions26
Accrued interest related to uncertain tax positions $ 300
Effective income tax rate17.00%(1.00%)
Malaysia
Operating Loss Carryforwards [Line Items]
Income tax benefit of tax holiday, amount $ 600 $ 100
Income tax benefit of tax holiday (in usd per share) $ 0.01 $ 0.01
Hungary
Operating Loss Carryforwards [Line Items]
Foreign statutory tax rate9.00%
Income tax expense benefit in foreign tax position $ 2,000 $ 200

Comprehensive income (Details)

Comprehensive income (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance $ 1,223,697 $ 1,224,871
Current-period other comprehensive (loss) income(765)2,642
Reclassified from accumulated OCI into income(1,173)2,056
Income tax (benefit) expense425 2,760
Ending Balance1,207,438 1,221,509
Currency translation adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance(23,179)(10,066)
Current-period other comprehensive (loss) income(3,805)(7,195)
Reclassified from accumulated OCI into income0 0
Income tax (benefit) expense0 0
Ending Balance(26,984)(17,261)
Investments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance0 (426)
Current-period other comprehensive (loss) income0 (88)
Reclassified from accumulated OCI into income0 0
Income tax (benefit) expense0 (2)
Ending Balance0 (512)
Derivative instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance3,048 (10,334)
Current-period other comprehensive (loss) income3,040 9,925
Reclassified from accumulated OCI into income(1,173)2,056
Income tax (benefit) expense425 2,762
Ending Balance4,490 (1,115)
Accumulated other comprehensive income/(loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance(20,131)(20,826)
Ending Balance $ (22,494) $ (18,888)

Authorized shares of common a_3

Authorized shares of common and preferred stock and stock-based compensation plans - Narrative (Details) - USD ($) $ / shares in Units, $ in MillionsJan. 01, 2021May 05, 2020May 12, 2015May 11, 2010May 10, 2005Mar. 31, 2022Mar. 31, 2021Jan. 19, 2022Dec. 31, 2021Oct. 23, 2019May 14, 2019May 14, 2013May 31, 2005Jan. 21, 2004
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common and preferred stock shares authorized (in shares)365,000,000
Preferred stock, authorized (in shares)5,000,000 5,000,000 5,000,000
Preferred stock, par value per share (in usd per share) $ 0.01 $ 0.01 $ 0.01
Common stock, authorized (in shares)360,000,000 360,000,000 3,000,000 360,000,000
Common stock, par value per share (in usd per share) $ 0.01 $ 0.01 $ 0.01
Maximum employee subscription rate15.00%
Preferred stock, issued (in shares)0 0
Preferred stock, outstanding (in shares)0 0
Common stock repurchased (in shares)772,052
Shares repurchased, weighted average price (in usd per share) $ 40.74
2019 Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized common stock available for repurchase (in shares)0 3,000,000
Common stock repurchased (in shares)0
2022 Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Board of Directors approved stock repurchase (up to) $ 250
Authorized common stock available for repurchase Amount $ 230
Series A Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, authorized (in shares)750,000
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted (in shares)164,843 130,006
Service period3 years3 years
Weighted average grant day fair value (in dollars per share) $ 59.65 $ 66.97
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of target shares granted0.00%
2005 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance (in shares)3,362,304 4,050,000
Award vesting period (in years)10 years
2005 Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)5 years
2005 Plan | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)3 years
2005 Plan | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)5 years
2005 Plan | Vesting period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)10 years
2010 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, authorized (in shares)3,000,000
Number of shares reserved for issuance (in shares)2,518,416
2010 Plan | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)3 years
2010 Plan | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)5 years
2010 Plan | Vesting period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)10 years
1994 Plan and the 2005 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance (in shares)3,362,304
2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional number of shares reserved for issuance (in shares)3,000,000
Shares available for grant under 2015 restricted stock plan (in shares)567,142
2015 Plan | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)3 years
2015 Plan | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)4 years
2015 Plan | Vesting period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)5 years
2015 Plan | Vesting period four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)10 years
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance (in shares)4,500,000
Shares available for grant under 2015 restricted stock plan (in shares)1,637,992
2020 Plan | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)1 year
2020 Plan | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)2 years
2020 Plan | Vesting period three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)3 years
2020 Plan | Vesting period four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)4 years
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of the lower of the market related to purchase of common stock85.00%
Common stock reserved for future issuance under employee stock purchase plan (in shares)1,797,679
Shares issued under employee stock purchase plan (in shares)263,842
Weighted average purchase price of employees' purchase rights (in usd per share) $ 35.04

Authorized shares of common a_4

Authorized shares of common and preferred stock and stock-based compensation plans (Details) - Performance Shares - simulation simulation in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of simulations100 100
Expected volatility37.81%40.60%
Expected life in years2 years 11 months 12 days2 years 11 months 12 days
Risk-free interest rate1.33%0.21%
Dividend yield2.52%2.66%

Segment and geographic inform_3

Segment and geographic information- Narrative (Details)3 Months Ended
Mar. 31, 2022segmentregion
Segment Reporting [Abstract]
Number of operating segments | segment1
Number of geographic regions company operates in | region3

Segment and geographic inform_4

Segment and geographic information - Schedule of Revenue by Geographic Region (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021Dec. 31, 2021
Segment Reporting Information [Line Items]
Total revenue $ 385,256 $ 335,182
Long-lived assets315,000 $ 312,000
United States
Segment Reporting Information [Line Items]
Total revenue152,000 120,000
Long-lived assets126,000 125,000
China
Segment Reporting Information [Line Items]
Total revenue55,000 54,000
Hungary
Segment Reporting Information [Line Items]
Long-lived assets52,000 51,000
Malaysia
Segment Reporting Information [Line Items]
Long-lived assets77,000 76,000
Rest of the World
Segment Reporting Information [Line Items]
Total revenue178,000 $ 161,000
Long-lived assets $ 60,000 $ 60,000

Debt - Narrative (Details)

Debt - Narrative (Details) - Secured Revolving Loan FacilityJun. 18, 2021USD ($)Mar. 31, 2022USD ($)
Credit Agreement
Line of Credit Facility [Line Items]
Unsecured revolving line of credit $ 500,000,000
Total leverage ratio3.50
Leverage ratio for material acquisitions4
Liquidity ratio leverage, minimum3
Credit Agreement | Federal funds rate
Line of Credit Facility [Line Items]
Variable interest rate spread0.50%
Credit Agreement | LIBOR
Line of Credit Facility [Line Items]
Variable interest rate spread1.00%
Credit Agreement | Minimum
Line of Credit Facility [Line Items]
Quarterly commitment fee0.15%
Credit Agreement | Minimum | LIBOR
Line of Credit Facility [Line Items]
Default interest rate2.00%
Credit Agreement | Minimum | LIBOR Margin
Line of Credit Facility [Line Items]
Variable interest rate spread0.25%
Credit Agreement | Minimum | LIBOR Plus Margin
Line of Credit Facility [Line Items]
Variable interest rate spread1.25%
Credit Agreement | Maximum
Line of Credit Facility [Line Items]
Quarterly commitment fee0.25%
Credit Agreement | Maximum | LIBOR Margin
Line of Credit Facility [Line Items]
Variable interest rate spread0.75%
Credit Agreement | Maximum | LIBOR Plus Margin
Line of Credit Facility [Line Items]
Variable interest rate spread1.75%
Credit Agreement | Letter of Credit
Line of Credit Facility [Line Items]
Unsecured revolving line of credit $ 25,000,000
Wells Fargo Revolving Credit Loan
Line of Credit Facility [Line Items]
Debt issuance costs $ 2,400,000

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt Instruments (Details) - USD ($) $ in ThousandsMar. 31, 2022Dec. 31, 2021
Line of Credit Facility [Line Items]
Total Debt, non-current $ 325,000 $ 300,000
Secured Revolving Loan Facility | Wells Fargo Revolving Credit Loan
Line of Credit Facility [Line Items]
Effective interest rate1.40%
Total Debt $ 325,000 $ 300,000

Commitments and contingencies -

Commitments and contingencies - Narrative (Details) $ in Millions3 Months Ended
Mar. 31, 2022USD ($)
Commitments and Contingencies Disclosure [Abstract]
Limited warranty on most hardware products (in number of years)1 year
Noncancellable unconditional purchase obligations $ 17.7

Commitments and contingencies_2

Commitments and contingencies - Schedule Of Warranty Reserve (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of the period $ 3,210 $ 2,872
Accruals for warranties issued during the period641 681
Accruals related to pre-existing warranties83 130
Settlements made (in cash or in kind) during the period(584)(803)
Balance at the end of the period $ 3,350 $ 2,880

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs $ 400 $ 6,275
Restructuring reserve9,813 $ 11,520
Employee Severance
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs $ 400

Restructuring - Summary of Char

Restructuring - Summary of Charges in Consolidated Statement of Operations (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs $ 400 $ 6,275
Cost of sales
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs0 75
Research and development
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs400 155
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs0 4,086
General and administrative
Restructuring Cost and Reserve [Line Items]
Total restructuring and other related costs $ 0 $ 1,959

Restructuring - Summary of Bala

Restructuring - Summary of Balance Sheet Activity (Details) - USD ($) $ in Thousands3 Months Ended
Mar. 31, 2022Mar. 31, 2021
Restructuring Reserve [Roll Forward]
Restructuring reserve $ 11,520
Income statement expense400 $ 6,275
Cash payments(2,107)
Restructuring reserve $ 9,813

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in ThousandsFeb. 28, 2022Oct. 19, 2021Oct. 31, 2021Mar. 31, 2022Jun. 30, 2021Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill $ 592,074 $ 575,992
Term loan facility | Wells Fargo Securities, LLC | Line of Credit
Business Acquisition [Line Items]
Proceeds from term loan $ 200,000
Heinzinger
Business Acquisition [Line Items]
Cash consideration $ 22,500
Goodwill14,000
Other intangible assets $ 7,000
NHR
Business Acquisition [Line Items]
Cash consideration $ 206,238
Goodwill $ 102,932
Outstanding shares acquired100.00%
Transaction costs $ 6,000
Cash acquired from acquisition $ 3,000
Increase to the fair value of acquired liabilities $ 5,100
Other Acquisitions
Business Acquisition [Line Items]
Cash consideration $ 20,000
Goodwill17,000
Other intangible assets $ 4,000

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Purchase Price Allocation (Details) - USD ($) $ in ThousandsOct. 19, 2021Mar. 31, 2022Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill $ 592,074 $ 575,992
NHR
Business Acquisition [Line Items]
Consideration Transferred $ 206,238
Cash2,935
Accounts receivable, net3,902
Inventories, net4,764
Property and equipment, net287
Other assets and liabilities(4,621)
Intangible assets98,510
Goodwill102,932
Accounts payable and accrued expenses(2,186)
Deferred revenue(285)
Net assets acquired $ 206,238

Acquisitions - Summary of Preli

Acquisitions - Summary of Preliminary Purchase Price Allocation and Useful Lives (Details) - NHR $ in ThousandsOct. 19, 2021USD ($)
Business Acquisition [Line Items]
Estimated Fair Value $ 98,510
Customer relationships
Business Acquisition [Line Items]
Estimated Fair Value $ 54,350
Estimated Useful Lives (in years)7 years
Developed software
Business Acquisition [Line Items]
Estimated Fair Value $ 6,010
Existing product configurations
Business Acquisition [Line Items]
Estimated Fair Value $ 28,300
Estimated Useful Lives (in years)9 years
In-process research and development (IPR&D)
Business Acquisition [Line Items]
Estimated Fair Value $ 4,030
Trade name
Business Acquisition [Line Items]
Estimated Fair Value $ 5,820
Estimated Useful Lives (in years)6 years
Minimum | Developed software
Business Acquisition [Line Items]
Estimated Useful Lives (in years)2 years
Maximum | Developed software
Business Acquisition [Line Items]
Estimated Useful Lives (in years)7 years

Acquisitions - Unaudited Pro Fo

Acquisitions - Unaudited Pro Forma Results (Details) - NHR $ in Thousands3 Months Ended
Mar. 31, 2021USD ($)
Business Acquisition [Line Items]
Net sales $ 342,935
Net income $ 3,884

Subsequent events (Details)

Subsequent events (Details) - $ / sharesApr. 20, 2022Mar. 31, 2022Mar. 31, 2021
Subsequent Event [Line Items]
Dividends declared per share (in usd per share) $ 0.28 $ 0.27
Subsequent event
Subsequent Event [Line Items]
Dividends declared per share (in usd per share) $ 0.28